MV-130 by Inmunotek for Lower Respiratory Tract Infections: Likelihood of Approval

MV-130 is under clinical development by Inmunotek and currently in Phase II for Lower Respiratory Tract Infections.

The importance of trust in AI as a medical device

Alison Dennis is a London-based partner with law firm Taylor Wessing, where she co-heads the international life sciences team specializing in regulatory and transactional representation.

June 15, 2023

Understanding how the body regulates circadian rhythms using mathematical models

Researchers are using mathematical models to better understand the effects of disruptions like daylight savings time, working night shifts, jet lag or even late-night phone

August 18, 2023

Cannabis use alters DNA methylation, with implications beyond smoking effects

A large-scale meta-analysis in Molecular Psychiatry reveals that lifetime cannabis use is associated with DNA methylation changes in peripheral blood, which could have implications for

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.